Xiangming Cheng

559 total citations
19 papers, 400 citations indexed

About

Xiangming Cheng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiangming Cheng has authored 19 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiangming Cheng's work include Renal cell carcinoma treatment (5 papers), Renal and related cancers (4 papers) and Cancer-related molecular mechanisms research (4 papers). Xiangming Cheng is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Renal and related cancers (4 papers) and Cancer-related molecular mechanisms research (4 papers). Xiangming Cheng collaborates with scholars based in China, Macao and United States. Xiangming Cheng's co-authors include Zhigang Ji, Zixing Ye, Xin Zhao, Wei Sun, Xiaoyan Liu, Hongqian Guo, Xiang Liu, Jingmin Zhou, Guanghua Liu and Jingmin Zhou and has published in prestigious journals such as International Journal of Cancer, Archives of Biochemistry and Biophysics and Aquaculture.

In The Last Decade

Xiangming Cheng

18 papers receiving 395 citations

Peers

Xiangming Cheng
Yelena Chernyavskaya United States
Ni Zheng China
Brian M. Ortmann United Kingdom
Jennifer E. Endress United States
Lillian Chow United States
Xiangming Cheng
Citations per year, relative to Xiangming Cheng Xiangming Cheng (= 1×) peers Nobuyuki Akita

Countries citing papers authored by Xiangming Cheng

Since Specialization
Citations

This map shows the geographic impact of Xiangming Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangming Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangming Cheng more than expected).

Fields of papers citing papers by Xiangming Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangming Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangming Cheng. The network helps show where Xiangming Cheng may publish in the future.

Co-authorship network of co-authors of Xiangming Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangming Cheng. A scholar is included among the top collaborators of Xiangming Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangming Cheng. Xiangming Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Huiying, Xiangming Cheng, Yudong Fang, et al.. (2025). Long non-coding RNA LINC01232 promotes malignancy of prostate cancer through regulation of miR-181a-5p/IRS2 pathway: Ki-67 protein molecular structure and function. International Journal of Biological Macromolecules. 306(Pt 4). 141817–141817.
2.
Wang, Shuang, et al.. (2021). LINC01006 regulates the proliferation, migration and invasion of hepatocellular carcinoma cells through regulating miR-433-3p/CBX3 axis. Annals of Hepatology. 25. 100343–100343. 13 indexed citations
3.
Li, Yangzhen, et al.. (2021). Dietary bile acid supplementation reveals beneficial effects on intestinal healthy status of tongue sole (Cynoglossus semiliaevis). Fish & Shellfish Immunology. 116. 52–60. 36 indexed citations
4.
Li, Yangzhen, et al.. (2021). Genetic parameter estimates for female proportion in tongue sole (Cynoglossus semilaevis). Aquaculture. 548. 737652–737652. 3 indexed citations
5.
Liu, Xiang, Mingxin Zhang, Xiangming Cheng, et al.. (2020). LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma. Frontiers in Oncology. 10. 717–717. 41 indexed citations
6.
Li, Jialin, et al.. (2020). Activation of FOXO3 pathway is involved in polyphyllin I-induced apoptosis and cell cycle arrest in human bladder cancer cells. Archives of Biochemistry and Biophysics. 687. 108363–108363. 16 indexed citations
9.
Cheng, Xiangming, et al.. (2019). Clinical research on stereotactic radiosurgery combined with epithermal growth factor tyrosine kinase inhibitors in the treatment of brain metastasis of non-small cell lung cancer.. PubMed. 24(2). 578–584. 8 indexed citations
10.
Cheng, Xiangming, Xiaoyan Liu, Xiang Liu, et al.. (2018). Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer. Frontiers in Oncology. 8. 494–494. 39 indexed citations
12.
Cheng, Xiangming, Mingxin Zhang, Yu Xiao, et al.. (2018). Interleukin-6-Producing Pheochromocytoma as a New Reason for Fever of Unknown Origin: A Retrospective Study. Endocrine Practice. 24(6). 507–511. 13 indexed citations
13.
Liu, Guanghua, et al.. (2018). Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1. Cancer Biology & Therapy. 19(11). 1039–1056. 45 indexed citations
14.
Liu, Xiaoyan, Xiangming Cheng, Xiang Liu, et al.. (2018). Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery. International Journal of Cancer. 143(2). 408–418. 48 indexed citations
15.
Cheng, Xiangming, et al.. (2017). Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype. Urologic Oncology Seminars and Original Investigations. 35(8). 530.e1–530.e6. 31 indexed citations
16.
Cheng, Xiangming, Weidong Gan, Gutian Zhang, Xiaogong Li, & Hongqian Guo. (2016). Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies. BMC Urology. 16(1). 40–40. 31 indexed citations
17.
Cheng, Xiangming, Jian He, Weidong Gan, et al.. (2015). Pseudocapsule of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a clue for tumor enucleation?. PubMed. 8(5). 5403–10. 12 indexed citations
18.
Cheng, Xiangming, Weidong Gan, Linfeng Xu, et al.. (2014). [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].. PubMed. 52(11). 856–60. 1 indexed citations
19.
Cheng, Xiangming, et al.. (2012). Effect of LY294002 on adriamycin-induced epithelial-mesenchymal transition in human breast carcinoma cells.. PubMed. 34(4). 319–23. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026